These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24085361)

  • 1. [Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?].
    Pelzer U; Sinn M; Stieler J; Riess H
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2084-8. PubMed ID: 24085361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-regression analysis to indirectly compare prophylaxis with dalteparin or enoxaparin in patients at high risk for venous thromboembolic events.
    Dranitsaris G; Jelincic V; Choe Y
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):233-42. PubMed ID: 22387576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dalteparin: new indication. Prophylaxis in medical patients: no advance.
    Prescrire Int; 2005 Feb; 14(75):14-5. PubMed ID: 15751168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
    Amin AN; Girard F; Samama MM
    Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
    Aikens GB; Rivey MP; Hansen CJ
    Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous thromboembolism using enoxaparin in day surgery: results of the SMART noninterventional study.
    Haas S; Hohmann V; Bramlage P
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):265-71. PubMed ID: 22084412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of venous thrombosis in medical patients: A real-world perspective.
    Richards GA; Schoeman HS
    Cardiovasc J S Afr; 2006; 17(5):251-4. PubMed ID: 17117230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of risk assessment and prophylaxis of venous thromboembolism in pregnancy.
    Krafft A
    Thromb Haemost; 2007 Dec; 98(6):1155-6. PubMed ID: 18064306
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).
    Riess H; Pelzer U; Hilbig A; Stieler J; Opitz B; Scholten T; Kauschat-Brüning D; Bramlage P; Dörken B; Oettle H
    BMC Cancer; 2008 Dec; 8():361. PubMed ID: 19055847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
    Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
    Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-duration venous thromboembolism prophylaxis for medical patients.
    Carson MP; Kuo YH
    Ann Intern Med; 2010 Nov; 153(10):689; author reply 689-90. PubMed ID: 21079233
    [No Abstract]   [Full Text] [Related]  

  • 14. Extended-duration venous thromboembolism prophylaxis for medical patients.
    Dentali F; Gianni M; Squizzato A
    Ann Intern Med; 2010 Nov; 153(10):688; author reply 689-90. PubMed ID: 21079232
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
    Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial.
    Pelzer U; Opitz B; Deutschinoff G; Stauch M; Reitzig PC; Hahnfeld S; Müller L; Grunewald M; Stieler JM; Sinn M; Denecke T; Bischoff S; Oettle H; Dörken B; Riess H
    J Clin Oncol; 2015 Jun; 33(18):2028-34. PubMed ID: 25987694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T; Malý R; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.